Saltar al contenido
debya
Español
Iniciar sesión Regístrate gratis
Ver en Bluesky Seguir esta cuenta

Ian Davis

@profiand.bsky.social did:plc:dapqm5jgjts5ocyx6pccmpa5

Prof of medicine | med oncologist | Head, Monash University Eastern Health Clinical School | Chair, ANZUP Cancer Trials Group | husband, father, grandfather, blessed | want to make a positive difference GU oncology starter pack: https://go.bsky.app/DtoXvaD

En Bluesky desde el

Seguidores
1.561
Siguiendo
279
Posts
686
Días en rankings
0

Resumen

Ian Davis (@profiand.bsky.social) es un usuario de Bluesky que se unió el 12 septiembre 2023. Tiene 1.561 seguidores, sigue a 279 cuentas y ha publicado 686 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Erin Reed@erininthemorning.com

    Devastating to learn about the passing of Patrick Stewart. Years ago, I watched “The Inner Light” from his time on Star Trek TNG, it was one of the best episodes I had ever seen. One of the best things I’ve ever watched. I may watch it again tonight. His memory will live on.

    Ver post
  • Erin Reed@erininthemorning.com

    Yup, can confirm, watching this episode tonight will definitely make you bawl.

    Ver post
  • Julian Sanchez@normative.bsky.social

    Same. There was something that felt really radical about having a TV hero whose superpower was not just intelligence but thoughtfulness, and a kind of moral seriousness. Who showed from that first episode that you “win” by seeking to understand what seems like a threat.

    Ver post
  • Adam Serwer@adamserwer.bsky.social

    The starkest thing about TNG compared to most space opera today is how much it presents the eruption of violence as a total catastrophe, rather than something awesome bsky.app/profile/norm...

    Ver post
  • South Australian immunoGENomics Cancer Institute@saigenci.bsky.social

    Discover how the DASL-HiCaP trial is changing the outlook for prostate cancer treatment. @saigenci.bsky.social Director @chrissweens1.bsky.social explains how a hormone-blocking drug dramatically lowered the risk of relapse among men with very high-risk disease. www.smh.com.au/national/wel...

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.